Who
Jennifer Fitzpatrick
CLO and Head of Program Mgmt.
Company insider
Files Form 4 as: CLO and Head of Program Mgmt., Sionna Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $2.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Sep 2025
- Last trade
- 17 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code A | —28,133 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code A | —28,132 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —103,140 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —103,140 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —103,140 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —103,140 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code A | —28,133 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code A | —28,132 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code M | $63K10,250 at $6.11 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $447K10,250 at $43.60 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,250 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,250 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code M | $63K10,250 at $6.11 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $447K10,250 at $43.60 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code M | $63K10,250 at $6.11 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $347K10,250 at $33.86 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,250 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,250 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Code M | $63K10,250 at $6.11 | filing |
| 5 Mar 2026filed 6 Mar 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $347K10,250 at $33.86 | filing |
News
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis ConferenceSION · manilatimes.net · 8 Oct 2026
0 headlines in the last 90 days name Jennifer Fitzpatrick; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.